tiprankstipranks
Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ:OLMA
US Market
OLMA
Olema Pharmaceuticals
RESEARCH TOOLSreports
Want to see OLMA full AI Analyst Report?

Olema Pharmaceuticals (OLMA) Stock News & Sentiment

974 Followers
Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
Premium
Company Announcements
Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
3d ago
8K
OLMA
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
Premium
Ratings
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
11d ago
OLMA
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
12d ago
OLMA
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point
Premium
Company Announcements
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point
23d ago
8K
OLMA
Olema Pharmaceuticals Adds Veteran Director to Support Growth
Premium
Company Announcements
Olema Pharmaceuticals Adds Veteran Director to Support Growth
25d ago
8K
OLMA
Olema Pharmaceuticals: Palazestrant Phase III Upside and Differentiated Pipeline Underpin Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Palazestrant Phase III Upside and Differentiated Pipeline Underpin Buy Rating
2M ago
OLMA
Buy Rating Reaffirmed on Palazestrant’s Differentiated Phase 3 Program and Favorable Risk‑Reward Profile for Olema
Premium
Ratings
Buy Rating Reaffirmed on Palazestrant’s Differentiated Phase 3 Program and Favorable Risk‑Reward Profile for Olema
2M ago
OLMA
More OLMA News >

OLMA News on the Web

Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
TipRanks News
Neutral
Olema Oncology to Highlight Its Advancing Pipeline at Three Major Investor Conferences
Market Chameleon
Neutral
J.P. Morgan Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)
TipRanks News
Bullish
LifeSci Capital Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)
TipRanks News
Bullish
Citi opens ‘upside 90-day catalyst watch’ on Olema Oncology
TipRanks News
Neutral
Goldman Sachs Sticks to Its Buy Rating for Olema Pharmaceuticals (OLMA)
TipRanks News
Bullish
Oppenheimer Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)
TipRanks News
Bullish
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
OLMA
Sector Average
Media Buzz
This Week5 articles
Weekly Average4 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OLMA’s Media Buzz Sentiment?
5 articles about OLMA were published this week. In an average week, 4 articles are published.
    What is OLMA’s weekly average amount of articles?
    In an average week, 4 articles about OLMA are published.
      What is OLMA’s News Sentiment?
      99% of articles about OLMA were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week